Please note, this OEL/ADE monograph also applies to cetrorelix acetate (CAS RN 145672-81-7), cetrorelix acetate[biacetate] (CAS RN 130143-01-0), and cetrorelix dicetrorelix pamoate, cetrorelix embonate (CAS RN 165186-69-6). Cetrorelix acetate is a synthetic decapeptide with antagonistic activity against gonadotropin-releasing hormone (GnRH). It controls the release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) by competing with natural GnRH for binding to membrane receptors on gonadotrophic cells of the anterior pituitary.", "This OEL and ADE monograph covers both Cetrorelix and Cetrorelix acetate (CAS RN 145672-81-7)
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Cetrorelix, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.